1 / 88
文档名称:

兽药企业财务分析课件.ppt

格式:ppt   大小:2,568KB   页数:88页
下载后只包含 1 个 PPT 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

兽药企业财务分析课件.ppt

上传人:读书百遍 2020/12/22 文件大小:2.51 MB

下载得到文件列表

兽药企业财务分析课件.ppt

文档介绍

文档介绍:Welcome
Kathy Makrakis Vice President Investor Relations
*
兽药企业财务分析专业版
*
Forward Looking Statement
Statements made in this presentation include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, including those relating to future financial expectations, involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward looking statements. Information on other significant potential risks and uncertainties not discussed herein may be found in the Company’s filings with the Securities and Exchange Commission including its Form 10K for the year ended December 31, 2005.
*
兽药企业财务分析专业版
*
Webcast Information and Presentation Assumptions
This presentation is available in a listen only mode via the internet at , , or until March 24, 2006.
These materials are meant for use only in connection with the oral presentation being made by the company at its analyst meeting on March 21, 2006 as many assumptions, risks and other facts material to the understanding of these slides will be presented at the conference. Since these materials were prepared specifically for the March 21, 2006 conference, the company does not undertake to update this material for developments, risks or circumstances after that date. The potential revenue opportunity related to growth initiatives in this presentation are based on assumptions which the company believes to be reasonable, but because they cover several years and, in many cases represent the estimated targets for new strategies, or the introduction of new products, they are subject to inherent risks, including risks disclosed in the company’s most recent 10K filing, that could cause actual results to vary materially.
*
兽药企业财务分析专业版
*
Agenda
TOPIC
PRESENTERS
Welcome and Agenda
Kathleen Makrakis
Vice President Investor Relations
Company Overview
Ingrid Wiik
Vice Chairman, President and CEO
F